GUTS Q3 2023 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$34M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36,000

Gross Profit

-$73,000-202.8% margin

Operating Income

-$14M-38536.1% margin

Net Income

-$16M-43741.7% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-50.0%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$57M

Total Liabilities

$63M

Stockholders' Equity

-$6M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36,000	$0	—
Gross Profit	-$73,000	$0	—
Operating Income	-$14M	-$12M	-20.1%
Net Income	-$16M	-$11M	-42.3%